Related Experiment Video
Updated: Apr 18, 2026
06:55
Protocol to Create Chronic Wounds in Diabetic Mice
Published on: September 25, 2019
22.2K
Normalizing dysfunctional purine metabolism accelerates diabetic wound healing
Andrew L Weinstein1, Frank D Lalezarzadeh, Marc A Soares
1Plastic Surgery, NYU Langone Medical Center, New York, New York.
Summary
Diabetic wound healing is impaired by oxidative stress from xanthine oxidase (XO). Inhibiting XO with siXDH reduced reactive oxygen species (ROS) and accelerated healing in diabetic models.
Area of Science:
- Biomedical Science
- Wound Healing Research
- Oxidative Stress Mechanisms
Background:
- Diabetic patients experience impaired wound healing due to factors like ischemia, inflammation, and oxidative stress.
- Xanthine oxidase (XO) is identified as a significant contributor to reactive oxygen species (ROS) overproduction in diabetic environments.
- XO inhibitors have shown potential in mitigating XO overactivity and associated ROS.
Purpose of the Study:
- To investigate the specific role of xanthine oxidase (XO) in diabetic wound pathophysiology.
- To evaluate the therapeutic impact of inhibiting XO activity on the wound healing process in diabetic models.
Main Methods:
- Diabetic wound models were treated with siXDH (xanthine dehydrogenase siRNA) to inhibit XO.
- Quantitative analysis included measuring XDH mRNA expression, XO activity, ROS levels, and wound burden.
- Wound healing timelines were assessed to determine the acceleration of the healing process.
Main Results:
- siXDH treatment significantly decreased XDH mRNA expression (51.6%) and XO activity (35.9%).
- Reactive oxygen species (ROS) levels were markedly reduced by 78.1% following siXDH treatment.
- Pathologic wound burden decreased by 31.5%, and wound healing was accelerated by 7 days (23.3%).
Conclusions:
- Xanthine oxidase (XO) is a key mediator of elevated oxidative stress in diabetic wounds.
- Targeted delivery of siXDH effectively normalizes XO metabolic activity, reducing ROS production.
- Inhibition of XO activity presents a promising therapeutic strategy for accelerating diabetic wound healing.
Related Concept Videos
01:31Diabetic Foot Ulcer
1
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory...
1
01:22Diabetic Neuropathy
6
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
6
01:28Diabetic Nephropathy
2
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
2
01:24Type II Diabetes II: Pathophysiology
2
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
2
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
82
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
82
01:26Type I Diabetes II: Pathophysiology
1
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
1